INTEC PHARMA LTD JERUSALEM
SHS
CUSIP: M53644106
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q1 21 | 1 | $0.00B | 890 | $0.00 |
| Q4 20 | 1 | $0.00B | 120,991 | $0.00 |
| Q3 20 | 23 | $0.00B | 4,514,302 | $0.00 |
| Q2 20 | 24 | $0.00B | 7,343,928 | $0.00 |
| Q1 20 | 17 | $0.00B | 5,955,951 | $0.00 |
| Q4 19 | 27 | $0.00B | 5,525,775 | $0.00 |
| Q3 19 | 35 | $0.00B | 5,828,158 | $0.00 |
| Q2 19 | 53 | $0.00B | 12,743,195 | $0.01 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.